SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-003717
Filing Date
2022-01-19
Accepted
2022-01-19 16:21:25
Documents
2
Period of Report
2022-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4069
2 EX-24 DOCUMENT attachment1.htm EX-24 3536
  Complete submission text file 0001209191-22-003717.txt   8921
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address METLIFE 200 PARK AVENUE NEW YORK NY 10166
Business Address
MCKENZIE DIANA (Reporting) CIK: 0001754648 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 22539031